Does DEUCRAVACITINIB Cause Product dose omission issue? 61 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Product dose omission issue have been filed in association with DEUCRAVACITINIB (SOTYKTU). This represents 2.6% of all adverse event reports for DEUCRAVACITINIB.
61
Reports of Product dose omission issue with DEUCRAVACITINIB
2.6%
of all DEUCRAVACITINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product dose omission issue From DEUCRAVACITINIB?
Of the 61 reports.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEUCRAVACITINIB. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does DEUCRAVACITINIB Cause?
Drug ineffective (228)
Acne (225)
Pruritus (187)
Rash (175)
Erythema (124)
Psoriasis (122)
Off label use (101)
Adverse event (74)
Mouth ulceration (72)
Folliculitis (65)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which DEUCRAVACITINIB Alternatives Have Lower Product dose omission issue Risk?
DEUCRAVACITINIB vs DEUTETRABENAZINE
DEUCRAVACITINIB vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUCRAVACITINIB vs DEVICE
DEUCRAVACITINIB vs DEXAMETHASONE
DEUCRAVACITINIB vs DEXAMETHASONE\DEXAMETHASONE